The Honest Guide To
Peptide Therapy
What the research actually says — the promising, the unproven, and the risky. From a physician practice that believes you deserve the full picture.
Education First, Selling Never
Most peptide content online falls into two camps: vendors overselling everything as a miracle molecule, or critics dismissing everything as snake oil. Neither is honest.
This guide covers every major peptide being discussed in the wellness space today — the ones with real clinical data, the ones with only animal studies, and the ones we think you should avoid entirely. We include the evidence, the limitations, and our honest clinical assessment of each one.
We are not selling peptides on this page. We are educating you so that if you choose to explore peptide therapy, you do it safely, with realistic expectations, and under proper medical supervision. Your body, your decision — but it should be an informed one.
How We Rate The Evidence
Every peptide on this page gets an honest evidence rating:
Strong Human Data
Peer-reviewed clinical trials in humans
Limited Human Data
Some human studies, limited in scope
Animal Studies Only
May or may not translate to humans
Minimal Evidence
Marketing claims exceed the science
The Good — Peptides With Real Promise
These peptides have meaningful research behind them. That does not mean they are proven safe or effective — it means the evidence warrants serious consideration under medical supervision.
BPC-157 (Body Protection Compound)
Limited human dataTissue Repair · Gut Health
The most-studied peptide for tissue healing. Derived from a protective protein found in gastric juice. Extensive animal research shows accelerated healing of tendons, ligaments, muscle, gut lining, and nerve tissue. Promotes new blood vessel formation and reduces inflammation. Can be administered subcutaneously near an injury site or orally for gastrointestinal applications — uniquely, BPC-157 survives stomach acid.
Our assessment: Strongest preclinical profile of any peptide on this page. Animal data is extensive and consistent. Human data is limited but early reports are encouraging. The oral route for gut healing is particularly interesting. Side effects are generally mild. Of all the peptides here, this has the most reasonable risk-benefit profile.
✓ BCHW would prescribe: Yes, for appropriate candidates
Thymosin Alpha-1
Strong human dataImmune Modulation
The peptide with the strongest clinical evidence on this entire page. FDA-approved in over 35 countries under the brand name Zadaxin for treating hepatitis B, hepatitis C, and immune deficiency. Enhances T-cell differentiation, increases natural killer cell activity, and activates dendritic cells. Acts as an immune modulator rather than a simple booster.
Our assessment: The rare peptide where evidence genuinely supports clinical use. Published human trials exist. Safety profile is well-characterized from decades of use in Asia and Europe.
✓ BCHW would prescribe: Yes, with documented immune dysfunction
CJC-1295 / Ipamorelin
Limited human dataBody Composition · Recovery · Sleep
A combination that stimulates your body's natural growth hormone production without suppressing your own (unlike synthetic HGH). CJC-1295 extends the signaling window. Ipamorelin triggers a selective GH pulse. Together they create sustained, natural-pattern growth hormone elevation.
Our assessment: Gold-standard growth hormone stack. Well-tolerated by most. However, long-term cancer risk from chronically elevated IGF-1 is not established. Absolute contraindication with any cancer history or elevated baseline IGF-1.
✓ BCHW would prescribe: Yes, with mandatory IGF-1 monitoring
AOD-9604
Limited human dataFat Metabolism
A modified fragment of human growth hormone that targets fat metabolism without the growth-promoting effects of full HGH. Stimulates fat breakdown and inhibits new fat formation without affecting blood sugar. Phase 2 clinical trials showed statistically significant but modest fat loss.
Our assessment: The program did not advance to Phase 3 — likely due to modest effect size rather than safety concerns. This is a metabolic nudge, not a weight loss solution. For patients who have optimized diet and exercise, it may be worth discussing.
✓ BCHW would prescribe: Case-by-case, as complement to GLP-1 program
TB-500 (Thymosin Beta-4)
Animal studies onlyTissue Repair · Recovery
Promotes cell migration to injury sites, blood vessel formation, and inflammation reduction. Works systemically rather than locally. Often combined with BPC-157 in the "Wolverine stack." Banned by WADA.
Our assessment: Promising animal data but essentially no human clinical data. Angiogenic properties are helpful for healing but potentially dangerous with any cancer history. We approach this cautiously.
⚬ BCHW would prescribe: Case-by-case, no cancer history
The Questionable — Hype Exceeds Evidence
These are widely discussed but the evidence does not yet support the claims being made. The science has not caught up to the marketing.
GHK-Cu (Copper Peptide)
Mixed evidenceAnti-aging · Skin Regeneration
Naturally occurring copper-binding peptide. Topical use for skin regeneration is well-established with human data. Injectable use for systemic anti-aging has far less evidence.
Our assessment: Topical is defensible. Injectable is speculative. If someone is selling you injectable GHK-Cu as an anti-aging miracle, the evidence does not support that claim.
⚬ BCHW position: Topical — yes. Injectable — not recommended
Selank & Semax
Limited (Russian studies)Cognitive Function · Anxiety
Neuropeptides developed and used clinically in Russia. Published human data exists but almost exclusively from Russian institutions and has not been replicated by Western researchers.
Our assessment: These may work, but we cannot be as confident in results from studies that haven't been replicated in randomized controlled trials in mainstream journals.
⚬ BCHW position: Would consider case-by-case with informed consent
DSIP (Delta Sleep-Inducing Peptide)
Minimal human dataSleep
Named for its purported ability to induce deep sleep. Despite the promising name, decades of research have failed to consistently demonstrate that DSIP reliably improves sleep in humans.
Our assessment: The name oversells the evidence. Better-studied sleep interventions (sleep hygiene, CBT-I, melatonin) should be tried first. Expectations should be very modest.
✗ BCHW would not recommend as a first-line sleep solution
MOTS-c
Animal studies onlyMetabolic Regulation · Exercise Performance
A mitochondrial-derived peptide generating interest in the longevity community. Studied for insulin sensitivity and fat metabolism in animal models. Discovered recently.
Our assessment: Interesting science, but years away from knowing whether this translates to humans. Watch the research, but don't pay for it yet.
✗ BCHW would not prescribe at this stage
Kisspeptin-10
Limited human dataHormone Regulation · Fertility
A neuropeptide being studied for fertility applications and as a diagnostic tool for reproductive hormone disorders. Primarily a research tool at this stage.
Our assessment: If someone is offering kisspeptin as a "hormone optimizer" in a commercial setting, that outpaces the evidence. Patients with fertility concerns should work with a reproductive endocrinologist.
✗ BCHW would not prescribe for optimization purposes
The Ugly — Approach With Extreme Caution
These are peptides where the risks outweigh the known benefits, the evidence is too thin to justify use, or the marketing claims are dangerously misleading. Including them here is not an endorsement — it is a warning.
Epitalon
Minimal evidenceAnti-aging / Longevity
Marketed as a telomere-lengthening peptide that reverses aging. Most published data comes from a single research group (Khavinson's) and has not been independently replicated. Studies are small, methodologically limited, and published in low-impact journals.
Our assessment: The claims are extraordinary. The evidence is not. If a provider is selling this as an anti-aging solution, ask for the human clinical trial data. They will not have it.
✗ BCHW would not prescribe
GHRP-2 & GHRP-6
Higher risk than alternativesGrowth Hormone Secretagogues
Older GH secretagogues that significantly increase cortisol, prolactin, and hunger hormones alongside growth hormone. GHRP-6 causes intense hunger spikes many patients find unmanageable.
Our assessment: Largely superseded by CJC-1295/Ipamorelin, which achieves similar GH elevation with far fewer side effects. If a provider prescribes these instead of CJC/Ipa, ask why.
✗ BCHW would not prescribe — better alternatives exist
Melanotan I & II
Significant safety concernsTanning · Cosmetic
Synthetic melanocyte-stimulating hormone analogs used for tanning. Linked to changes in existing moles and potential melanoma risk. Multiple case reports document new or changing moles after use.
Our assessment: Using a peptide that stimulates the exact cells that cause melanoma — the deadliest skin cancer — for cosmetic tanning is a risk-benefit calculation that clearly falls on the side of risk. We strongly advise against these for any purpose.
✗ BCHW would not prescribe
Gray-Market "Research" Peptides
UnregulatedAny Peptide From Unregulated Sources
Peptides sold online as "research chemicals" with "not for human use" labels. No FDA oversight, no batch testing, no purity guarantees. Bacterial endotoxins, heavy metals, wrong concentrations, and degradation products have all been documented. The largest vendor (Peptide Sciences) shut down in March 2026 following FDA enforcement.
Our assessment: The cost difference between gray-market and properly compounded peptides is $50–150 per month. That is a small price for knowing what is actually in the vial you are injecting into your body.
✗ BCHW strongly advises against any gray-market sourcing
Popular Peptide Stacks
Peptides are rarely used alone. Providers combine them into "stacks" — coordinated protocols where each peptide targets a different mechanism. Here are the most common combinations.
The Wolverine Stack
Limited + AnimalBPC-157+TB-500
Goal: Maximum Injury Recovery
BPC-157 works locally near the injury site. TB-500 works systemically to promote cell migration throughout the body. Together: targeted local repair + systemic recovery support.
Our assessment: Most popular stack in peptide therapy. BPC-157 alone may provide most benefit with less risk. Cancer history = BPC-157 only.
✓ BCHW would prescribe: Yes, for appropriate candidates with no cancer history
The GLP-1 Companion Stack
Theoretical rationaleBPC-157+AOD-9604±CJC/Ipa
Goal: Support Ozempic, Mounjaro, and Wegovy Outcomes
BPC-157 addresses GI side effects that cause many patients to discontinue GLP-1 therapy. AOD-9604 provides additional fat metabolism support. Optional CJC/Ipa adds muscle preservation — critical since GLP-1 patients can lose significant lean mass.
Our assessment: Sound rationale but no clinical trials of this specific combination. Start with BPC-157 alone for GI issues. Full stack only after optimizing diet, exercise, and protein.
✓ BCHW would prescribe: Yes — natural extension of our GLP-1 program
The Gut Healing Stack
Mixed evidenceBPC-157 oral+KPV+Larazotide
Goal: Gut Lining Repair & Inflammation Reduction
BPC-157 orally promotes gut repair. KPV targets gut inflammation. Larazotide regulates tight junctions to reduce intestinal permeability — it has Phase 3 clinical trial data for celiac disease. All oral administration — no injections.
Our assessment: Most clinically interesting gut stack. Larazotide has the strongest evidence of any peptide for gut applications. Oral-only route is accessible for injection-averse patients.
✓ BCHW would prescribe: Yes, especially for GI issues not responding to conventional treatment
The Immune Resilience Stack
Strong + AnimalThymosin Alpha-1+LL-37
Goal: Immune System Support
Thymosin Alpha-1 modulates adaptive immunity (T-cells, NK cells). LL-37 targets innate immunity by directly killing bacteria, viruses, and fungi. Together: both arms of the immune system.
Our assessment: TA1 is the strongest component with real human data. LL-37 is the weaker link. Start with TA1 alone. Add LL-37 only if immune markers do not improve after 8 weeks.
⚬ BCHW: TA1 alone — yes. Full stack — case-by-case after TA1 trial
The Anti-Aging "Kitchen Sink"
Weak overallCJC/Ipa+BPC-157+GHK-Cu+Epitalon
Goal: Comprehensive Anti-Aging · $500–1,000+/month
What expensive longevity clinics sell. Four peptides targeting multiple pathways simultaneously.
Our assessment: This is where peptide therapy starts to look like wellness theater. Stacking four peptides with varying evidence does not multiply the evidence — it multiplies the unknowns. Your provider should be helping you spend less, not more.
✗ BCHW would not prescribe as a full stack. We would not prescribe Epitalon.
Why Physician Supervision Matters
Screening matters. A patient with undiagnosed cancer who starts CJC-1295/Ipamorelin could accelerate tumor growth. Proper screening catches contraindications before they become emergencies.
Baseline labs matter. Without pre-protocol bloodwork (CBC, CMP, liver panel, IGF-1), neither you nor your provider can detect problems early. If your provider does not order labs, find a different provider.
Sourcing matters. FDA-registered 503B compounding pharmacies test every batch and provide Certificates of Analysis. Gray-market vendors do not.
Monitoring matters. Dose adjustments, cycle management, side effect assessment, and follow-up labs are all part of responsible prescribing.
Knowing when to stop matters. A good provider recognizes when a protocol is not working and adjusts or discontinues — rather than escalating doses.
FDA Regulatory Update
FDA Advisory Panel: July 23–24, 2026
The FDA will review whether seven peptides should be reclassified from Category 2 (restricted from compounding) back to Category 1 (eligible for compounding). A second meeting covering five additional peptides is planned before February 2027. BCHW has established relationships with compliant compounding pharmacies and is prepared to offer physician-supervised peptide therapy when the regulatory path clears.
What this does NOT mean: Reclassification does not mean peptides become FDA-approved drugs. It means compounding pharmacies can legally manufacture them. The responsibility for appropriate use still falls on the prescribing physician and the patient.
Stay Informed
Be the first to know when BCHW launches peptide therapy, when the FDA rules, and when we publish new content. No spam, no selling — just the update you're waiting for.
Free Reconstitution Calculator
Calculate your draw volume, concentration, and doses per vial. Always follow your provider's specific instructions.
Reconstitution Calculator
Enter your vial size, water volume, and prescribed dose
Peptide vial size
mg
Bacteriostatic water added
mL
Your prescribed dose
mcg
Syringe type
Concentration5,000 mcg/mL
Draw this amount
5
units on your syringe
Volume to draw0.050 mL
Doses per vial40 doses
Frequently Asked Questions
Are peptides legal? +
Peptides exist in a regulatory gray zone. They are not FDA-approved drugs, but physicians can prescribe them as compounded medications through licensed compounding pharmacies. Several are currently restricted from compounding but under active review for reclassification. BCHW will only offer peptide therapy through compliant, FDA-registered compounding pharmacies.
Do I need a prescription? +
Yes. Therapeutic peptides require a physician prescription. At BCHW, you will have a consultation to evaluate whether peptide therapy is appropriate, complete necessary lab work, and receive a specific protocol if indicated. Prescriptions are filled by licensed compounding pharmacies.
How much does peptide therapy cost? +
Costs vary by peptide and protocol. Typical monthly costs range from $100 to $400 for the peptide itself, plus consultation fees. Peptide therapy is not covered by insurance. HSA/FSA funds may be eligible.
Can I buy peptides without a doctor? +
You can find peptides online labeled "for research use only." We strongly advise against this. These products are unregulated, untested, and potentially contaminated. The cost savings compared to properly compounded peptides are $50–150 per month — not worth the risk.
Can I combine peptides with GLP-1 medication? +
In many cases, yes. BPC-157 can help with GI side effects common on GLP-1 medications, while AOD-9604 supports fat metabolism. However, combining therapies requires careful medical oversight. If you are a BCHW GLP-1 patient, your provider can evaluate whether adding peptides is appropriate.
What side effects should I watch for? +
Common side effects include injection site redness, mild nausea, fatigue, and occasional headaches. Growth hormone peptides can cause water retention and tingling. Serious side effects are rare with proper sourcing and physician oversight. See each peptide's section above for specifics.
What lab work do I need? +
Baseline labs should include: complete blood count (CBC), comprehensive metabolic panel (CMP), liver function panel, IGF-1, and lipid panel. Follow-up labs are recommended at 4–6 weeks and periodically throughout treatment.
Have Questions?
Start With A Conversation.
Book a consultation with a BCHW provider. We'll give you an honest assessment — including telling you if peptides aren't the right fit.
Book a Consultation Join the Waitlist
The information on this page is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendation. Peptides discussed are not FDA-approved drugs. Compounded peptides have not been reviewed by the FDA for safety, effectiveness, or quality. All medical decisions should be made with a qualified healthcare provider.
© 2026 Bluff City Health & Wellness · 2200 Union Ave, Memphis TN 38104 · (901) 209-1484
© 2026 Bluff City Health & Wellness · 2200 Union Ave, Memphis TN 38104 · (901) 209-1484